Psychosomatics
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Psychosomatics 49:225-229, May 2008
doi: 10.1176/appi.psy.49.3.225
© 2008 Academy of Psychosomatic Medicine
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Google Scholar
* Articles by Dieperink, E.
* Articles by Ho, S. B.
PubMed
* PubMed Citation
* Articles by Dieperink, E.
* Articles by Ho, S. B.
Related Collections
* Posttraumatic Stress Disorder
* Syndromes Secondary to General Medical Disorders

The Effect of Pegylated Interferon-{alpha}2b and Ribavirin on Posttraumatic Stress Disorder Symptoms

Eric Dieperink, M.D., Jennie Leskela, Ph.D., Michael E. Dieperink, M.D., Ph.D., Blake Evans, Ph.D., Paul Thuras, Ph.D., and Samuel B. Ho, M.D.

Received January 25, 2006; revised August 15, 2006; accepted August 30, 2006. From the Depts. of Psychiatry and the Hepatitis C Resource Center at the VA Medical Center; Univ. of Minnesota Medical School; and the Dept. of Medicine, VA San Diego Healthcare System and the Univ. of California, San Diego. Send correspondence and reprint requests to Dr. Eric Dieperink, VA Medical Center (116A), Dept. of Psychiatry, One Veterans Dr., Minneapolis, MN 55417. e-mail: Eric.Dieperink{at}med.va.gov
© 2008 The Academy of Psychosomatic Medicine

BACKGROUND: Patients with chronic psychiatric diagnoses have a prevalence of chronic hepatitis C (HCV) approximately 11 times higher than the general American population. Posttraumatic stress disorder (PTSD) is particularly common among HCV patients. OBJECTIVE: The authors describe the effect of treatment with pegylated-interferon-{alpha}2b (IFN) and ribavirin for patients with HCV on their posttraumatic stress disorder (PTSD) symptoms. METHOD: Sixteen patients with HCV and combat-related PTSD were followed for 24 weeks and assessed with self-report measures of PTSD, hostility, and depression. RESULTS: Depression and Resentment scores significantly increased in five patients treated with IFN and ribavirin, but no significant differences were found in PTSD scores when compared with 11 control patients. CONCLUSION: The results suggest that patients with PTSD and HCV can be safely treated with anti-viral therapies when they are given appropriate psychiatric care.

Key Words: Interferon • PTSD







Get information about faster international access.

Privacy Policy

Copyright © 2008 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. Academy of Psychosomatic Medicine
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org